Needham & Company LLC Reiterates “Hold” Rating for Sage Therapeutics (NASDAQ:SAGE)
Sage Therapeutics (NASDAQ:SAGE – Get Free Report)‘s stock had its “hold” rating reissued by equities research analysts at Needham & Company LLC in a report issued on Friday,Benzinga reports. Several other brokerages also recently weighed in on SAGE. Bank of America started coverage on Sage Therapeutics in a research note on Tuesday, March 11th. They […]
